This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation - Product Development Awards Committee A


The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.

Committee members - Product Development Awards Selection Committee A

Mr Mark Kirby (Chair) Chief Executive SmartTarget Limited Mr Kirby is an experienced MedTech chairman with experience of start-up to exit challenges. His specialties include strategy, fundraising, building teams and growing businesses.
Professor Paul Sibbons (Deputy Chair) Independent pre-clinical Consultant Independent Consultant Professor Sibbons has extensive experience in pre-clinical surgery, pathology, evaluation and interpretation.
Mr Ravi Chana Head of Business Development
Roche Diagnostics Limited Ravi has a broad range of expertise in Business Development, Market Access, Health Economics, MedTech Commercialisation and Value Based Healthcare
Ms Mary Anne Cordeiro Consultant to life science businesses Science to Business Ltd Ms Cordeiro is an experienced advisor and merchant banker to innovative companies in the healthcare sector, specifically in medical technology businesses. She has been working on the commercialisation and funding of innovative products and services since 1998 after a 15-year career as an investment banker
Ms Alice Evans Co-Head, Governance and Sustainable Investment BMO Global Asset Management (EMEA) Ms Evans has extensive fund management experience running global equity funds with a focus on environmental, social and governance (ESG) issues, and specialises in the healthcare sector
Professor Gail Hayward Associate Professor
 University of Oxford  Gail is experienced in diagnostics and infectious diseases research in primary care
Dr Eldrid Herrington Public Committee Member PPI  Representative PPI  Representative
Professor David Jayne Professor (Clinical) University of Leeds Professor Jayne's expertise range from General surgery with coloproctology sub specialisation; Robotic & minimally invasive surgery; Gastrointestinal oncology; Global Surgery
Dr Thomas Keeble Cardiologist and Honorary Senior Clinical Lecturer The Essex Cardiothoracic Centre and Anglia Ruskin University Dr Keeble is an experienced cardiologist and senior clinical lecturer who primarily focuses on interventional cardiology and general cardiovascular research
Dr Zahid Latif Innovation and Supply Chain Specialist (LSO) Life Sciences Organisation Dr Latif is a qualified pharmacist with specialities in pharmaceutical drug discovery, natural product chemistry, pharmacy, regenerative medicine, cell based therapies and digital health
Professor James Moore The Bagrit and Royal Academy of Engineering Chair in Medical Device Design Imperial College London Professor Moore's interests include Cardiovascular Biomechanics, Implantable Devices, and the Lymphatic System. Received multiple patents for medical devices and co-founded two startups
Ms Stella O'Brien Public Committee Member PPI Representative  PPI Representative
Dr Nick de Pennington  CEO Ufonia Limited Nick is CEO and Founder of a health AI company; Innovation Lead at Oxford University Hospitals; former Clinical Lead of an NHS regional digital interoperability programme, and has a background as a neurosurgeon with over 15 years of frontline clinical experience
Dr Krishan Ramdoo Research Fellow Northwick Park Institute for Medical Research Dr Krishan has clinical, academic and commercial expertise. He has expertise in developing a product starting from a lab bench to commercial product. His academic project was funded and commerciased by initiating a company (TympaHealth). Dr. Krishan developed All-in-One Hearing Assessment System which is a class 1 and CE marked medical software. Moreover, it was approved by the FDA.
Dr Matthew Reeves Senior Lecturer University College London Dr Reeves has a specialty in infectious diseases focusing primarily on human cytomegalovirus latency and reactivation, and viral pathogenesis in human transplantation
Dr Julie Simmonds Executive Director, Equity Research Panmure Gordon Dr Simmonds is experienced with investment and financial analysis in the healthcare sector, including medical devices and biotechnology in small/medium UK companies and large European stocks
Dr Andrew Sims Head of Department, Northern Medical Physics and Clinical Engineering The Newcastle upon Tyne Hospitals NHS Foundation Trust Dr Sims is a medical physicist specialising in health technology assessment, translational R&D and outcomes research with real-world healthcare data, mainly in med-tech and diagnostics
Dr Gill Vivian Head of department, Nuclear medicine King's College Hospital Dr Vivian has experience in diagnostic imaging, specialising in nuclear medicine. She has clinical and research experience in oncological imaging with focus on endocrine oncology
Dr Peter Watkinson Associate Professor of Intensive Care Medicine John Radcliffe Hospital Dr Watkinson is a Consultant in intensive care and acute medicine. He has designed and run a number of studies in the field of wearable devices for monitoring patient deterioration in the hospital setting
Dr Glenn Wells Chief Operating Officer Oxford Academic Health Centre Dr Wells is an experienced professional in the life science and healthcare sector, particularly in funding and management of translational research & development of national policy
Mr Tim Wright Chief Executive Officer  Aqdot Mr Wright is an experienced CEO with a background in the healthcare sector and pharmaceuticals. He has successfully developed, licensed and grown brands and businesses at all stages of their lifecycle